Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1).

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 8625974)

Published in Eur J Immunol on April 01, 1996

Authors

A M Arvilommi1, M Salmi, K Kalimo, S Jalkanen

Author Affiliations

1: National Public Health Institute, Finland. anna-maija.arvilommi@utu.fi

Articles citing this

Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol (2008) 2.83

Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol (1998) 2.05

Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med (1998) 1.61

Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection. Am J Pathol (1999) 1.39

Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J Exp Med (1997) 1.18

In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol (2000) 1.03

Mouse vascular adhesion protein 1 is a sialoglycoprotein with enzymatic activity and is induced in diabetic insulitis. Am J Pathol (1999) 0.91

Selective upregulation of endothelial E-selectin in response to Helicobacter pylori-induced gastritis. Infect Immun (2009) 0.82

Study on SSAO enzyme activity and anti-inflammatory effect of SSAO inhibitors in animal model of inflammation. J Neural Transm (Vienna) (2012) 0.77

Platelet, not endothelial, P-selectin expression contributes to generation of immunity in cutaneous contact hypersensitivity. Am J Pathol (2010) 0.77

Adhesion molecules in cutaneous immunity. Semin Immunopathol (2007) 0.75

Articles by these authors

Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol (1987) 3.84

Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med (1989) 3.68

Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet (1990) 3.55

IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease. Lancet (1983) 3.17

A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science (1986) 2.91

Homing receptors and the control of lymphocyte migration. Immunol Rev (1986) 2.26

A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science (1992) 2.06

Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.80

Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear. Circ Res (2000) 1.61

Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med (1998) 1.61

Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med (1993) 1.58

A solid-phase radioimmunoassay for IgG and IgM antibodies against measles virus. J Gen Virol (1977) 1.56

Evolutionary conservation of tissue-specific lymphocyte-endothelial cell recognition mechanisms involved in lymphocyte homing. J Cell Biol (1988) 1.51

Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. J Exp Med (1995) 1.48

Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J Cell Biol (1997) 1.46

How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol (1997) 1.43

VAP-1: an adhesin and an enzyme. Trends Immunol (2001) 1.41

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med (1995) 1.37

Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases. Gastroenterology (1994) 1.37

Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol (1993) 1.35

Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol (1993) 1.34

Cell surface monoamine oxidases: enzymes in search of a function. EMBO J (2001) 1.26

Herpes simplex encephalitis: A serological follow-up study. Synthesis of herpes simplex virus immunoglobulin M, A, and G antibodies and development of oligoclonal immunoglobulin G in the central nervous system. Acta Neurol Scand (1981) 1.24

A cell surface amine oxidase directly controls lymphocyte migration. Immunity (2001) 1.24

Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes (1996) 1.23

Immune cell trafficking in uterus and early life is dominated by the mucosal addressin MAdCAM-1 in humans. Gastroenterology (2001) 1.22

Ly-6C regulates endothelial adhesion and homing of CD8(+) T cells by activating integrin-dependent adhesion pathways. Proc Natl Acad Sci U S A (1997) 1.20

Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol (1998) 1.20

CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism. J Immunol (2000) 1.19

Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology (1996) 1.19

HLA-B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells. Eur J Immunol (1997) 1.18

Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J Exp Med (1997) 1.18

Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med (2001) 1.17

Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J Exp Med (1996) 1.17

Prevalence of atopic disorders among adolescents in Turku, Finland. Allergy (1992) 1.16

Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J (2001) 1.13

Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J Immunol (1998) 1.13

Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol (1992) 1.11

Contact allergy to dental restorative materials in patients with oral lichenoid lesions. Contact Dermatitis (1997) 1.07

Parental education in the treatment of childhood atopic eczema. Acta Derm Venereol (1990) 1.06

Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol (2001) 1.05

Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. J Am Coll Cardiol (2000) 1.05

Human lymphocyte and lymphoma homing receptors. Annu Rev Med (1987) 1.05

Human vascular adhesion protein-1 in smooth muscle cells. Am J Pathol (1999) 1.04

Molecules controlling lymphocyte migration to the gut. Gut (1999) 1.04

Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology (2000) 1.04

Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Invest (1997) 1.04

Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology (1996) 1.03

In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol (2000) 1.03

Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium. J Immunol (1993) 1.02

Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models. Eur J Immunol (1995) 1.02

Lymphocyte migration into the skin: the role of lymphocyte homing receptor (CD44) and endothelial cell antigen (HECA-452). J Invest Dermatol (1990) 1.01

Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. FASEB J (2001) 1.00

Circulating IgA- and IgG-class antigliadin antibodies in dermatitis herpetiformis detected by enzyme-linked immunosorbent assay. Arch Dermatol Res (1983) 1.00

Course of hand dermatitis in hospital workers. Contact Dermatitis (1982) 0.98

YadA mediates specific binding of enteropathogenic Yersinia enterocolitica to human intestinal submucosa. Infect Immun (1994) 0.98

CD73 mediates adhesion of B cells to follicular dendritic cells. Blood (1996) 0.97

Cross-reactivity of IgE antibodies with allergens in birch pollen, fruits and vegetables. Int Arch Allergy Appl Immunol (1984) 0.96

Contact allergy to various components of topical preparations for treatment of external otitis. Acta Otolaryngol (1986) 0.96

Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity. J Immunol (1998) 0.96

Cell adhesion and migration. IV. Lymphocyte trafficking in the intestine and liver. Am J Physiol (1998) 0.95

Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues. Proc Natl Acad Sci U S A (1992) 0.95

Yersinia lipopolysaccharide is modified by human monocytes. Infect Immun (1993) 0.94

A multicenter study of patch test reactions with dental screening series. Am J Contact Dermat (2001) 0.94

Immunological detection of proteins after isoelectric focusing in thin layer agarose gel: a specific application for the characterization of immunoglobulin diversity. J Clin Lab Immunol (1983) 0.94

Regulation of lymphocyte traffic to mucosa-associated lymphatic tissues. Gastroenterol Clin North Am (1991) 0.94

Flow cytometric analysis of the Hermes homing-associated antigen on human lymphocyte subsets. Blood (1989) 0.93

Candida albicans and atopic dermatitis. Clin Exp Allergy (1993) 0.93

IgE antibodies to protein and mannan antigens of pityrosporum ovale in atopic dermatitis patients. Clin Exp Allergy (1997) 0.93

Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy. Leukemia (2012) 0.93

Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes. Infect Immun (1997) 0.92

Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD. Inflamm Bowel Dis (1998) 0.92

IgE, IgA, and IgG responses to common yeasts in atopic patients. Allergy (1998) 0.92

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Br J Cancer (1993) 0.92

Structural model of the catalytic domain of an enzyme with cell adhesion activity: human vascular adhesion protein-1 (HVAP-1) D4 domain is an amine oxidase. Protein Eng (1998) 0.92

Mouse vascular adhesion protein 1 is a sialoglycoprotein with enzymatic activity and is induced in diabetic insulitis. Am J Pathol (1999) 0.91

Patch test reactions to cosmetic allergens in 1995-1997 and 2000-2002 in Finland--a multicentre study. Contact Dermatitis (2005) 0.91

In vitro lymphocyte proliferation test in the diagnosis of oral mucosal hypersensitivity reactions to dental amalgam. J Oral Pathol Med (1997) 0.91

Prevalence of nickel allergy among Finnish university students in 1995. Contact Dermatitis (2001) 0.91

Serum CD44 in malignant lymphoma: an association with treatment response. Blood (1994) 0.90